Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study

Delivery of therapeutic agents as erythropoietin (EPO) into Central Nervous System through intranasal route could benefit patients with neurological disorders. A new nasal formulation containing a non-hematopo...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2sEmoX3
via IFTTT